Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Ainos, Inc.

Market Cap 15.02M 13.06M 12.01M 11.3M 21.18M 1.42B 21.42M 143M 55.39M 697M 56.38M 55.18M 2.41B P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 25.61M 22.26M 20.48M 19.26M 36.09M 2.42B 36.5M 243M 94.41M 1.19B 96.1M 94.04M 4.11B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
33.62%
Yield 2024 *
-
Yield 2025 -
1 day+8.51%
Current month-14.29%
1 month+20.00%
3 months+42.66%
6 months-5.12%
Current year+24.39%
1 week 1.82
Extreme 1.82
2.16
1 month 1.45
Extreme 1.4513
3.88
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.5
3 years 1.26
Extreme 1.26
30.5
5 years 1.26
Extreme 1.26
645
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap.
05/06Buy

Director

3,500 0.0501%
03/06Buy

Director

2,000 0.0286%
28/05Buy

Director

250 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
+8.51%0.00%-18.98%-88.96% 13.85M
-2.31%-6.55%+13.98%-14.07% 176B
-3.57%-5.73%-22.51%+22.11% 148B
-1.98%-5.65%-11.61%-26.48% 128B
-4.20%-8.19%-55.71%-17.25% 69.74B
-2.14%-0.98%+15.85%-5.72% 51B
-1.84%-1.25%-24.74%-34.38% 45.7B
-3.12%-8.23%+4.46%+2.64% 36.25B
-0.98%-3.81%+2.64%+32.62% 35.4B
-3.29%-7.36%-16.07%-22.25% 28.76B
Average +0.84%-3.29%-11.27%-15.17% 71.86B
Weighted average by Cap. +0.79%-3.05%-9.43%-7.04%

Financials

2024 2025
Net sales 20.73K 18.02K 16.58K 15.59K 29.22K 1.96M 29.55K 197K 76.42K 962K 77.79K 76.13K 3.33M 124K 108K 99.28K 93.38K 175K 11.73M 177K 1.18M 458K 5.76M 466K 456K 19.94M
Net income -14.86M -12.92M -11.89M -11.18M -20.95M -1.4B -21.19M -141M -54.8M -690M -55.78M -54.59M -2.39B -14.77M -12.84M -11.81M -11.11M -20.82M -1.4B -21.06M -140M -54.46M -686M -55.43M -54.25M -2.37B
Net Debt 8.11M 7.05M 6.48M 6.1M 11.43M 766M 11.56M 77.08M 29.89M 376M 30.43M 29.77M 1.3B 10.58M 9.2M 8.46M 7.96M 14.92M 1B 15.09M 101M 39.02M 491M 39.72M 38.87M 1.7B
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
17/06/26 2.040 $ +8.51% 43,357
16/06/26 1.880 $ +2.17% 44,157
15/06/26 1.840 $ -3.66% 56,958
12/06/26 1.910 $ -0.52% 25,852
11/06/26 1.920 $ +1.59% 50,516
  1. Stock Market
  2. Stocks
  3. AIMD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!